Connection
Theodore Randolph to Powders
This is a "connection" page, showing publications Theodore Randolph has written about Powders.
|
|
Connection Strength |
|
 |
|
 |
|
0.510 |
|
|
|
-
Witeof AE, McClary WD, Rea LT, Yang Q, Davis MM, Funke HH, Catalano CE, Randolph TW. Atomic-Layer Deposition Processes Applied to Phage ? and a Phage-like Particle Platform Yield Thermostable, Single-Shot Vaccines. J Pharm Sci. 2022 05; 111(5):1354-1362.
Score: 0.199
-
Xu Y, Grobelny P, Von Allmen A, Knudson K, Pikal M, Carpenter JF, Randolph TW. Protein quantity on the air-solid interface determines degradation rates of human growth hormone in lyophilized samples. J Pharm Sci. 2014 May; 103(5):1356-66.
Score: 0.115
-
Clausi AL, Morin A, Carpenter JF, Randolph TW. Influence of protein conformation and adjuvant aggregation on the effectiveness of aluminum hydroxide adjuvant in a model alkaline phosphatase vaccine. J Pharm Sci. 2009 Jan; 98(1):114-21.
Score: 0.080
-
Jarmer DJ, Lengsfeld CS, Anseth KS, Randolph TW. Supercritical fluid crystallization of griseofulvin: crystal habit modification with a selective growth inhibitor. J Pharm Sci. 2005 Dec; 94(12):2688-702.
Score: 0.065
-
Webb SD, Golledge SL, Cleland JL, Carpenter JF, Randolph TW. Surface adsorption of recombinant human interferon-gamma in lyophilized and spray-lyophilized formulations. J Pharm Sci. 2002 Jun; 91(6):1474-87.
Score: 0.051
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|